These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27060007)

  • 21. Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.
    Khalil F; Läer S
    AAPS J; 2014 Mar; 16(2):226-39. PubMed ID: 24399240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and optimisation of current milrinone prescribing for the treatment and prevention of low cardiac output syndrome in paediatric patients after open heart surgery using a physiology-based pharmacokinetic drug-disease model.
    Vogt W
    Clin Pharmacokinet; 2014 Jan; 53(1):51-72. PubMed ID: 23839530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating Tacrolimus Disposition in Paediatric Patients with a Physiologically Based Pharmacokinetic Model Incorporating CYP3A4 Ontogeny, Mechanistic Absorption and Red Blood Cell Binding.
    Van der Veken M; Brouwers J; Ozbey AC; Umehara K; Stillhart C; Knops N; Augustijns P; Parrott NJ
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically based pharmacokinetic modelling of semaglutide in children and adolescents with healthy and obese body weights.
    Machado TR; Honorio T; Souza Domingos TF; Candido de Paula DDS; Cabral LM; Rodrigues CR; Abrahim-Vieira BA; Teles de Souza AM
    Br J Clin Pharmacol; 2023 Oct; 89(10):3175-3194. PubMed ID: 37293836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products - a PEARRL review.
    Guimarães M; Statelova M; Holm R; Reppas C; Symilllides M; Vertzoni M; Fotaki N
    J Pharm Pharmacol; 2019 Apr; 71(4):603-642. PubMed ID: 29971768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive tools and critical strategies for development of best fit PBPK model aiming better in vitro-in vivo correlation.
    Golhar A; Pillai M; Dhakne P; Rajput N; Jadav T; Sengupta P
    Int J Pharm; 2023 Aug; 643():123267. PubMed ID: 37488057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Affecting Successful Extrapolation of Ibuprofen Exposure from Adults to Pediatric Populations After Oral Administration of a Pediatric Aqueous Suspension.
    Statelova M; Holm R; Fotaki N; Reppas C; Vertzoni M
    AAPS J; 2020 Nov; 22(6):146. PubMed ID: 33184711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines.
    Wollmer E; Ungell AL; Nicolas JM; Klein S
    Adv Drug Deliv Rev; 2022 Feb; 181():114084. PubMed ID: 34929252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopharmaceutic IVIVE-Mechanistic Modeling of Single- and Two-Phase In Vitro Experiments to Obtain Drug-Specific Parameters for Incorporation Into PBPK Models.
    Pathak SM; Schaefer KJ; Jamei M; Turner DB
    J Pharm Sci; 2019 Apr; 108(4):1604-1618. PubMed ID: 30476508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations.
    Rhee SJ; Chung H; Yi S; Yu KS; Chung JY
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):973-980. PubMed ID: 28536774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the impact of acid-reducing agents on drug absorption using biorelevant in vitro tools and PBPK modeling - case example dipyridamole.
    Segregur D; Barker R; Mann J; Moir A; Karlsson EM; Turner DB; Arora S; Dressman J
    Eur J Pharm Sci; 2021 May; 160():105750. PubMed ID: 33581261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.
    Berlin M; Ruff A; Kesisoglou F; Xu W; Wang MH; Dressman JB
    Eur J Pharm Biopharm; 2015 Jun; 93():267-80. PubMed ID: 25872159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of
    Loisios-Konstantinidis I; Dressman J
    Mol Pharm; 2021 Jan; 18(1):1-17. PubMed ID: 33320002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paediatric oral biopharmaceutics: key considerations and current challenges.
    Batchelor HK; Fotaki N; Klein S
    Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the Oral Absorption of Irbesartan Using Biorelevant Dissolution Testing and PBPK Modeling.
    Kaur N; Thakur PS; Shete G; Gangwal R; Sangamwar AT; Bansal AK
    AAPS PharmSciTech; 2020 Mar; 21(3):102. PubMed ID: 32152915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets.
    Beloica S; Cvijić S; Bogataj M; Parojčić J
    Eur J Pharm Sci; 2015 Jul; 75():151-9. PubMed ID: 25861718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.